Evidence map›Paper›PMID 40231310›Full record

ArticleRespirology case reports2025

Tracheobronchial Amyloidosis: A Rare Airway Disorder With Diagnostic and Therapeutic Challenges-A Case Report and Literature Review.

Filip Shterev, Vladimir Aleksiev, Veselin Chonov, Boyko Yavorov, Stanislav Kartev, Dimcho Argirov

Abstract read
In one paragraph

Article in Respirology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Filip ShterevI-st Department of Internal Diseases, Section of Pneumology and Phthysiatrics Medical University of Plovdiv Plovdiv Bulgaria.
Vladimir AleksievClinic of Thoracic Surgery Plovdiv University Multiprofile Hospital for Active Treatment Kaspela Plovdiv Bulgaria.ORCID https://orcid.org/0009-0004-7860-6632
Veselin ChonovDepartment of Clinical Pathology Plovdiv University Multiprofile Hospital for Active Treatment Kaspela Plovdiv Bulgaria.
Boyko YavorovClinic of Thoracic Surgery Plovdiv University Multiprofile Hospital for Active Treatment Kaspela Plovdiv Bulgaria.
Stanislav KartevI-st Department of Internal Diseases, Section of Pneumology and Phthysiatrics Medical University of Plovdiv Plovdiv Bulgaria.
Dimcho ArgirovClinic of Thoracic Surgery Plovdiv University Multiprofile Hospital for Active Treatment Kaspela Plovdiv Bulgaria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tracheobronchial amyloidosis (TBA) is a rare, localised form of amyloidosis characterised by the extracellular deposition of abnormal proteins within the tracheal and bronchial tissues. This condition, although uncommon, can significantly impact airway function, leading to symptoms such as persistent cough, dyspnea and airway obstruction. This report highlights the clinical presentation, diagnostic approaches and therapeutic options for TBA, emphasising the need for individualised management strategies and comprehensive patient care. This case describes a 62-year-old male with a history of smoking debuting with progressive hoarseness, dyspnea and dysphagia, who was initially diagnosed with tracheobronchial amyloidosis following biopsy of a subglottic mass. After surgical excision and a 3-year disease-free interval, he experienced multiple recurrences requiring further interventions, including bronchoscopic evaluation. Histopathological confirmation of recurrent amyloidosis led to a decision for strict follow-up, as symptoms remained mild post-biopsy.

Indexed as

airway obstructionbronchoscopyprotein depositiontherapeutic managementtracheobronchial amyloidosis

Identifiers

PMID40231310
PMCPMC11994858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.